Biohit Oyj - Managers' Transactions
Biohit Oyj - Managers' Transactions, March 3, 2017 at 11:10 am local time (EET)
Person subject to the notification requirement |
Name: |
Hendolin, Panu |
|
Position: |
Other senior manager |
|
|
|
Initial Notification |
|
Reference number: |
74370089ATTSNBXJVT29_20170303094228_1 |
|
|
|
Issuer |
Name: |
Biohit Oyj |
LEI: |
74370089ATTSNBXJVT29 |
|
|
|
Transaction details |
Transaction date: |
2017-03-01 |
Venue: |
NASDAQ HELSINKI LTD (XHEL) |
Nature of the transaction: |
Disposal |
|
Instrument: |
Share |
ISIN: |
FI0009005482 |
|
Volume: |
1100 |
Unit price: |
5,33000 Euro |
|
Aggregated transactions |
Volume: |
1100 |
Volume weighted average price: |
5.33000 Euro |
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com
|